Oncology & Cancer

Scientists find cancer weak spots for new targeted drugs

A major computational analysis by scientists at the University of Sussex and The Institute of Cancer Research, London, has found a number of potential targets for drugs that exploit the inherent weaknesses of cancer cells.

Medical research

Taking technology from the lab to the patient

After finishing his PhD in molecular genetics in the late 1990s, Daniel Anderson found himself conflicted about what to do next: He enjoyed science, but wanted to find a way to have a direct impact on human health.

Oncology & Cancer

High risk of bowel cancer for gene carriers

Researchers from the University of Melbourne have found that screening for bowel cancer in genetically high-risk populations should begin early.

Oncology & Cancer

New pathway for stalling BRCA tumor growth revealed

Inhibiting the action of a particular enzyme dramatically slows the growth of tumor cells tied to BRCA1 and BRCA2 genetic mutations which, in turn, are closely tied to breast and ovarian cancers, according to researchers ...

Genetics

An enzyme that fixes broken DNA sometimes destroys it instead

Enzymes inside cells that normally repair damaged DNA sometimes wreck it instead, researchers at the Stanford University School of Medicine have found. The insight could lead to a better understanding of the causes of some ...

page 28 from 40